03 September 2026

Autoimmune CAR-T trials paused after patient deaths

7 minute read

Novartis and Bristol Myers Squibb have paused enrolment in their autoimmune CAR-T trials following three deaths associated with severe inflammatory reactions to rapidly manufactured CAR-T therapies.

This content is for AHPRA registered professionals only.
Login Join Now

End of content

No more pages to load

Register for a new account

Email Address

Password

Confirm Password

First Name

Last Name

Full Name LEAVE THIS BLANK

What field do you work in?

Type of University work:

Industry Specialty:

Other:

Billing Address

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

I agree to the Terms and conditions and privacy policy *

Processing...

Autoimmune CAR-T trials paused after patient deaths

Redefining ‘stable’ in SLE

FDA approves first oral dermatomyositis drug

Cannabis-linked early psychosis isn’t just a young-person problem

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Log in

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover